Steven D. Ertel, EVP & Chief Operating Officer at ACCELERON PHARMA INC (XLRN), sold 2,000 shares at $30.46 ($61K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Scheduled sale ($61k) by EVP & Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-07-17 | $63K | — | Filing → |